These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29931686)

  • 1. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
    Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia.
    Hennig A; Salel M; Sacher F; Camaioni C; Sridi S; Denis A; Montaudon M; Laurent F; Jais P; Cochet H
    Europace; 2018 Sep; 20(FI2):f179-f191. PubMed ID: 29069369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
    J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Nonischemic Dilated Cardiomyopathy With Incidental Infarction From Ischemic Cardiomyopathy by Geometric Indices Derived From Cardiovascular Magnetic Resonance.
    Wang X; Costello BT; Papapostolou S; O'Brien J; Taylor A; Zhao S
    J Thorac Imaging; 2021 Jul; 36(4):248-253. PubMed ID: 32960835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global longitudinal strain evaluated by speckle-tracking echocardiography as a surrogate marker for predicting replacement fibrosis detected by magnetic resonance-late gadolinium enhancement in patients with nonischemic cardiomyopathy.
    Ota S; Hozumi T; Tanimoto T; Takemoto K; Wada T; Kashiwagi M; Shimamura K; Shiono Y; Kuroi A; Matsuo Y; Kitabata H; Ino Y; Kubo T; Tanaka A; Akasaka T
    J Clin Ultrasound; 2021 Jun; 49(5):479-487. PubMed ID: 33527434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
    Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance-based predictors of complete left ventricular systolic functional recovery after rhythm restoration in patients with atrial tachyarrhythmia.
    Stegmann C; Jahnke C; Lindemann F; Oebel S; Richter S; Bollmann A; Dagres N; Hindricks G; Paetsch I
    Europace; 2022 Jan; 24(1):12-19. PubMed ID: 34279613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis.
    Wang J; Yang F; Wan K; Mui D; Han Y; Chen Y
    ESC Heart Fail; 2020 Oct; 7(5):2184-2192. PubMed ID: 32603034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gadolinium enhancement among survivors of sudden cardiac arrest.
    Neilan TG; Farhad H; Mayrhofer T; Shah RV; Dodson JA; Abbasi SA; Danik SB; Verdini DJ; Tokuda M; Tedrow UB; Jerosch-Herold M; Hoffmann U; Ghoshhajra BB; Stevenson WG; Kwong RY
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):414-423. PubMed ID: 25797123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies.
    Peretto G; Sala S; Lazzeroni D; Palmisano A; Gigli L; Esposito A; De Cobelli F; Camici PG; Mazzone P; Basso C; Della Bella P
    Heart Lung Circ; 2020 Sep; 29(9):1356-1365. PubMed ID: 32299760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased myocardial native T
    Nakamori S; Bui AH; Jang J; El-Rewaidy HA; Kato S; Ngo LH; Josephson ME; Manning WJ; Nezafat R
    J Magn Reson Imaging; 2018 Mar; 47(3):779-786. PubMed ID: 28737018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
    Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
    Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.
    Peretto G; Barison A; Forleo C; Di Resta C; Esposito A; Aquaro GD; Scardapane A; Palmisano A; Emdin M; Resta N; Santoni A; Guaricci AI; Santobuono VE; Pepe M; Favale S; Ferrari M; Benedetti S; Della Bella P; Sala S
    Europace; 2020 Dec; 22(12):1864-1872. PubMed ID: 32995851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
    Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy.
    Hooks M; Okasha O; Velangi PS; Nijjar PS; Farzaneh-Far A; Shenoy C
    Eur Heart J Cardiovasc Imaging; 2021 Nov; 22(12):1425-1433. PubMed ID: 33026088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinus rhythm QRS amplitude and fractionation in patients with nonischemic cardiomyopathy to identify ventricular tachycardia substrate and location.
    Arceluz MR; Liuba I; Tschabrunn CM; Frankel DS; Santangeli P; Supple GE; Schaller RD; Garcia FC; Callans DJ; Guandalini GS; Walsh K; Nazarian S; Zado ES; Marchlinski FE
    Heart Rhythm; 2022 Feb; 19(2):187-194. PubMed ID: 34601127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.